Skip to main content
OpenTrials

Clinical trial condition

Diabetes Mellitus, Type 2

Explore clinical trials studying Diabetes Mellitus, Type 2. Study availability and eligibility vary by location and protocol.

8,020 public trials 711 recruiting studies
Refine in advanced search Browse all conditions

Diabetes Mellitus, Type 2 trial results

Completed

A Research Study Looking at How Semaglutide Works in People With Type 2 Diabetes in United Kingdom, as Part of Local Clinical Practice (SURE UK)

NCT03876015

Conditions
Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +3 more
Locations
  • Novo Nordisk Investigational Site Atherstone, United Kingdom
  • Novo Nordisk Investigational Site Berkshire, United Kingdom
  • Novo Nordisk Investigational Site Bradford, United Kingdom
  • Novo Nordisk Investigational Site Brighton, United Kingdom
View all 31 locations
View Trial Details
Completed

Dose-response, Safety and Efficacy of Oral Semaglutide Versus Placebo and Versus Liraglutide, All as Monotherapy in Japanese Subjects With Type 2 Diabetes

NCT03018028

Conditions
Diabetes, Diabetes Mellitus, Diabetes Mellitus, Type 2, +4 more
Locations
  • Novo Nordisk Investigational Site Akita-shi, Akita, Japan
  • Novo Nordisk Investigational Site Arakawa-ku, Tokyo, Japan
  • Novo Nordisk Investigational Site Ebina-shi, Kanagawa, Japan
  • Novo Nordisk Investigational Site Gunma, Japan
View all 16 locations
View Trial Details
Completed

Multiple Dose Trial Examining Dose Range, Escalation and Efficacy of Oral Semaglutide in Subjects With Type 2 Diabetes

NCT01923181

Conditions
Diabetes, Diabetes Mellitus, Diabetes Mellitus, Type 2, +4 more
Locations
  • Novo Nordisk Investigational Site Tucson, Arizona, United States
  • Novo Nordisk Investigational Site Chula Vista, California, United States
  • Novo Nordisk Investigational Site Long Beach, California, United States
  • Novo Nordisk Investigational Site Poway, California, United States
View all 103 locations
View Trial Details
Completed

A Research Study to Compare the Effect of Insulin Degludec and Insulin Glargine on Blood Sugar Levels in People With Type 2 Diabetes - the SWITCH PRO Study

NCT03687827

Conditions
Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +3 more
Locations
  • Novo Nordisk Investigational Site Chandler, Arizona, United States
  • Novo Nordisk Investigational Site Tucson, Arizona, United States
  • Novo Nordisk Investigational Site Fresno, California, United States
  • Novo Nordisk Investigational Site Lancaster, California, United States
View all 67 locations
View Trial Details

Related conditions